Search Results 3011-3020 of 22469 for oral

  1. A Study to Evaluate the Safety and Effectiveness of Ustekinumab as Initial or Maintenance Therapy for Patients with Moderately to Severely Active Ulcerative Colitis - Mayo Clinic

    Participation eligibility · Oral or IV corticosteroids · Immunomodulators (6-MP or AZA).

  2. Cognitive Change in Behavioral Variant Frontotemporal Dementia (FTD) - Mayo Clinic

    Must speak and understand oral and written English. · Must have probable bvFTD. · Must have a global Clinical Dementia Rating (CDR) score of 0.5-1 and a Mini ...

  3. A Study to Evaluate the Effect of a Medically-tailored Meal Service on Changes in Diabetic Patients' A1c - Mayo Clinic

    Fasting blood sugar of greater than 140 mg/dl, on no oral hypoglycemic agents and a hemoglobin A1C less than 13%. Stabilized patients on oral hypoglycemic ...

  4. Curriculum - Pediatric Anesthesiology Fellowship (Minnesota) - Mayo Clinic College of Medicine & Science

    Fellows have access to multiple examiners from the American Board of Anesthesiology (ABA) for oral board preparation and receive active mentorship and guidance ...

  5. Study of Critical Outcomes in Pregnant Patients on Insulin Pump with Type 1 Diabetes - Mayo Clinic

    Participant did not start insulin at diagnosis but upon investigator review likely needed insulin (significant hyperglycemia that did not respond to oral agents) ...

  6. Publications - Scott C. Lester, M.D. - Mayo Clinic

    Oral Oncol. 2024 Feb; 149:106675. Epub 2024 Jan 11. View PubMed; Foote RL, Harmsen WS, Amundson AC, Carr AB, Gamez ME, Garces YI, Lester SC, Ma DJ, McGee LA ...

  7. MBI Response toTam - Mayo Clinic

    Hormonal contraception (oral, transdermal, implanted, or injected formulations) Hormonal IUDs are allowed; Selective estrogen receptor modulators (tamoxifen ...

  8. informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia - Mayo Clinic

    The purpose of the InformCLL Registry is to characterize and describe treatment patterns for those initiating treatment with approved oral kinase inhibitors ...

  9. A Study of the Safety, Pharmacodynamics, Effectiveness, and PK of TIMP-GLIA in Subjects with Celiac Disease - Mayo Clinic

    ... oral gluten challenge. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health ...

  10. Department and Faculty - Maxillofacial Prosthetics and Dental Oncology Fellowship (Minnesota) - Mayo Clinic College of Medicine & Science

    In 1935, advanced programs in oral surgery became available through the Mayo Graduate School. By 1966, three additional dental residencies had formed ...